PADI4, His, Human

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
GSC-Z05729-100	100 µg		-		Request delivery time estimate		887.00€
GSC-Z05729-500	500 µg		-		Request delivery time estimate		2,943.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk... more

Close menu

Product information "PADI4, His, Human"

Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes.

Keywords:	PADI4, HL-60 PAD, Peptidylarginine deiminase IV, Protein-arginine deiminase type-4, Protein-arginine deiminase type IV
Supplier:	GenScript
Supplier-Nr:	Z05729

Properties

Conjugate:	No
Species reactivity:	human
MW:	76.6 kD
Purity:	>95% (Bis-Tris PAGE)

Database Information

KEGG ID :	K24669 \| Matching products
UniProt ID :	Q9UM07 \| Matching products
Gene ID :	GeneID 23569 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	-20°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "PADI4, His, Human"

Write a review